High threshold clinical responses (Investigator’s Global Assessment Score 0 or 1, and Psoriasis Area and Severity Index ... while IZAR-2 will enroll patients with an inadequate response to tumor ...
The use of IL-17 inhibitors in patients with psoriasis was associated with an increased risk for fungal infections when compared with other biologics.
Tumour Necrosis Factor TNF is crucial for defence but can drive chronic inflammation linked to arthritis and autoimmune diseases when overproduced ...
Investigators aimed to highlight aspects that may predict the time to relapse among patients with psoriasis who discontinued use of biologic therapy.
Learn about interactions between Enbrel and other medications, supplements, foods, alcohol, and more. You can also find out ...
Alopecia areata was more likely to develop in patients with inflammatory bowel disease (IBD) who were taking anti–tumor necrosis factor (TNF) therapy at the onset of the condition.
The anti-IL-23 monoclonal antibody, called picankibart, was shown to clear or nearly clear all lesions after 16 weeks among 48.2% of the 82 participating Chinese patients that were classified as ...
Innovent Biologics (IVBXF) announced the latest clinical results of a multicenter, open-label Phase 2 study of picankibart, a recombinant ...
A total of 152 patients, previously treated with marketed biologics for plaque psoriasis—including IL-17 inhibitors and TNF-α inhibitors—were enrolled. Patients with prior inadequate response at ...
In a systematic review, the incidence of gastrointestinal-related adverse events associated with the use of biologic therapies for psoriasis was 8.7%.
Lab studies conducted in 2017 showed that bai hua she she cao is able to reduce inflammatory compounds associated with psoriasis, such as tumor necrosis factor. By doing so, the herbal remedy may not ...
Al Michaels had no use for the Saints’ first-half foolishness Thursday night. Michaels sarcastically ripped the Saints for taking a timeout before a kneeldown to end the first 30 minutes in ...